[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f-dC9tVWtKAFWu6FnOC1CO4ygsqssA4Yv3M6p65nGjVo":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":32,"type":33},[],"2025-06-20 19:54:37",205420565,[8,9,10,11,12],"药物所处环境的 pH","患者的精神状态","肝、肾功能状态","药物血浆蛋白率高低","肾小球滤过率高低",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},120,"53e1d2ef4961cca8eea3e23969ad2cb9","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","默认课程","f717516301a645c1a8db86193076d757","课本附加","影响药物吸收的因素是()",[22,34,40,49,59,66,76,86,96,106],{"answer":23,"createTime":5,"id":24,"options":25,"question":31,"source":32,"type":33},[],205420556,[26,27,28,29,30],"药物预防、治疗疾病的理论和方法","药物与生物体之间相互作用机制和规律","药物和人体之间相互作用及其规律","人体对药物的处置过程","药物对人体的治疗作用","临床药理学是研究( )","v1",0,{"answer":35,"createTime":5,"id":36,"options":37,"question":39,"source":32,"type":33},[],205420557,[28,38,29,26,27],"药物在人体内效应部位的浓度与药效之间的关系","药物治疗学是研究( )",{"answer":41,"createTime":5,"id":42,"options":43,"question":48,"source":32,"type":33},[],205420558,[44,38,45,46,47],"遗传因素对于药效学、药动学及毒性的影响","以群体健康人和患者为对象,主要任务是评价药物","以患者为对象,研究药物及其剂型与病体相互作用和应用规律","药物和人体之间相互作用及其规律的学科","临床药学是研究( )",{"answer":50,"createTime":5,"id":51,"options":52,"question":58,"source":32,"type":33},[],205420559,[53,54,55,56,57],"以动物为实验对象,研究新药的药效学、药动学及毒性","研究药物剂型因素、生物因素与药效之间的关系","在患者或健康志愿者中进行的试验药品的系统性研究","已批准上市的药品,对其安全有效性及费用等做出科学评估","以人为研究对象,研究新药的药效学、药动学及毒性","市场药物的再评价是指( )",{"answer":60,"createTime":5,"id":61,"options":62,"question":65,"source":32,"type":33},[],205420560,[63,64],"临床护师 D.临床药理工作者","临床药师 E.临床药学工作者","药学服务(药学监护)主要由( )负责完成",{"answer":67,"createTime":5,"id":68,"options":69,"question":75,"source":32,"type":33},[],205420561,[70,71,72,73,74],"Emax不变,曲线右移","Emax下降,曲线下移","Emax不变,曲线左移","Emax下降,曲线上移","Emax不变,曲线下移","应用竞争性拮抗药后,受体激动药的量效曲线变化表现为()",{"answer":77,"createTime":5,"id":78,"options":79,"question":85,"source":32,"type":33},[],205420562,[80,81,82,83,84],"目标浓度","治疗指数","稳态血药浓度","有效血药浓度范围","血药浓度治疗区间","最低有效浓度和最低毒副反应浓度之间的血药浓度范围称为()",{"answer":87,"createTime":5,"id":88,"options":89,"question":95,"source":32,"type":33},[],205420563,[90,91,92,93,94],"变态反应","遗传因素决定的不良反应","获得性异常","先天性敏感性增高引起的其他反应","后遗效应","患者由于注射青霉素而发生过敏性休克的原因是()",{"answer":97,"createTime":5,"id":98,"options":99,"question":105,"source":32,"type":33},[],205420564,[100,101,102,103,104],"新药的毒副反应","新药的疗效","新药的不良反应处理方法","新药体内过程及给药方案","比较新药与已知药的疗效","药物代谢动力学研究的内容是()",{"answer":107,"createTime":5,"id":6,"options":108,"question":20,"source":32,"type":33},[],[8,9,10,11,12]]